Antibiotic therapy for Listeria monocytogenes bacteremia.
Listeria monocytogenes has been recognized as an important pathogen in immunocompromised patients, but it has been rarely reported in Taiwan. We reviewed 13 cases of L. monocytogenes bacteremia at National Taiwan University Hospital over a 12-year period. All of the patients had underlying diseases. Fever was the most common presenting symptom, and neurologic signs were found in 6 patients. Most of the patients received penicillin G, ampicillin or piperacillin with an aminoglycoside. Corticosteroids were used in 9 of 13 patients. The overall mortality directly due to L. monocytogenes bacteremia was 31%. However, patients treated with cephalosporins or oxacillin had higher mortality than those treated with penicillin G, ampicillin or piperacillin (p = 0.05). Given the increasing number of immunosuppressed patients in Taiwan, it is likely that more cases will be encountered. Physicians in Taiwan should be aware of L. monocytogenes bacteremia and its treatment.
Hung
C C
CC
Department of Internal Medicine, National Taiwan University Hospital, Taipei, R.O.C.
Chang
S C
SC
Chen
Y C
YC
Hsieh
W C
WC
Luh
K T
KT
D000293:Adolescent; D000328:Adult; D000368:Aged; D016470:Bacteremia / Q000188:drug therapy*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008089:Listeria monocytogenes; D008088:Listeriosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010406:Penicillins / Q000627:therapeutic use*; D011379:Prognosis
D010406:Penicillins